Pharmalot
By Ed Silverman
February 19, 2010

Grassley, who is the ranking Republican on the US Senate Finance Committee, is investigating the relationship between WebMD and drugmakers after learning the web site is running a TV ad that encourage people to take a depression-screening test sponsored by Eli Lilly, which sells Cymbalta.

So he wants WebMD, which lots of folks visit for medical info, to disclose its ties to the industry, in general, because the Lilly sponsorship raises questions about WebMD’s “independence,” according to this Feb. 18 letter to WebMD exec Wayne Gattinella. The ad encourages people to visit WebMD’s site to take a depression-screening test.

Read entire article:  http://www.pharmalot.com/2010/02/grassley-probes-webmd-ties-to-eli-lilly/

« Return to news items

News Feed

Related Posts

• Senator Grassley Investigates WebMD Links to Eli Lilly & WebMD’s ad for people to undergo a Lilly “depression screening” (0)
• Doctors rarely face consequences for drug kickbacks (0)
• Selling Depression—Adding New Spin and Urgency to Depression Drug Sales (0)
• Its about time…With drug companies paying criminal fines of $7 billion, FDA to increase prosecution of Pharma Execs (0)
• Pharma spends billions marketing to doctors; Eli Lilly paid $22 million in first 3 months of the year (0)

Tags: conflicts of interest, Cymbalta, Eli Lilly, screening, Senator Charles Grassley, US Senate Finance Committee, WebMD

This entry was posted on Saturday, February 20th, 2010 at 3:03 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.